[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352341-105":59,"doc-detail-352341-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","t-cell-exhaustion-in-hepatocellular-carcinoma-a-substantial-barrier-in-immunotherapy","T Cell Exhaustion in Hepatocellular Carcinoma - A Substantial Barrier in Immunotherapy","","Hepatocellular carcinoma (HCC), responsible for over 90% of primary liver cancers, remains a major clinical challenge worldwide. Although immunotherapy reshapes cancer treatment, immune resistance frequently limits benefit, notably through T cell exhaustion that undermines effective anti-tumour immunity in solid tumours including HCC. Persistent antigen exposure and tumour microenvironmental pressure drive progressive loss of T cell function. Epigenomic, transcriptomic, signalling pathway, and tumour metabolomic changes, together with microenvironmental interactions, promote exhaustion. This review outlines key cellular and molecular drivers and evaluates current and emerging strategies such as immune checkpoint blockade, epigenetic modulation, metabolic reprogramming, and combination therapies aimed at preventing or reversing exhaustion to improve outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/t-cell-exhaustion-in-hepatocellular-carcinoma-a-substantial-barrier-in-immunotherapy/352341/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/t-cell-exhaustion-in-hepatocellular-carcinoma-a-substantial-barrier-in-immunotherapy/352341.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is T cell exhaustion considered a major barrier to immunotherapy in hepatocellular carcinoma (HCC)?","Question",{"text":112,"@type":113},"In HCC, continuous antigen stimulation and an immunosuppressive tumour microenvironment drive T cells into a dysfunctional state known as T cell exhaustion, which prevents effective anti-tumour responses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do tumour-related molecular changes contribute to T cell exhaustion?",{"text":117,"@type":113},"As tumours progress, alterations in the epigenome, transcriptome, signalling pathways, and tumour metabolome—along with interactions within the tumour microenvironment—efficiently support the development of T cell exhaustion.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of strategies are discussed for preventing or reversing T cell exhaustion?",{"text":121,"@type":113},"The review discusses approaches including epigenetic modulation, immune checkpoint blockade, metabolic reprogramming, and combination therapies designed to restore T cell function and improve therapy outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352341,1790296537,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Journal of Cellular and Molecular Medicine   \n REVIEW  OPEN ACCESS   \nT Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy  \nKosar Nouri1 | Negar Asadollahei1 | Yasamin Haghir-Sharif-Zamini1 | Homeyra Seydi1 | Mahsa Salehi2 | Mehrnaz Mesdaghi3,4 | Mustapha Najimi5,6  | Massoud Vosough1,7,8   \n1Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran | 2Biological Products and Blood Safety Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran | 3Department of Allergy and Clinical Immunology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 4Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 5Laboratory of Pediatric  \nHepatology and Cell Therapy, Institute of Experimental and Clinical Research, UCLouvain, Brussels, Belgium | 6Private University of Marrakesh, Marrakesh, Morocco | 7Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden | 8Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran  \nCorrespondence: Mehrnaz Mesdaghi ([mehrnaz_mesdaghi@yahoo.com](mehrnaz_mesdaghi@yahoo.com)) | Mustapha Najimi ([mustapha.najimi@uclouvain.be](mustapha.najimi@uclouvain.be)) | Massoud Vosough ([masvos@royaninstitute.org](masvos@royaninstitute.org))  \nReceived: 8 August 2025 | Revised: 6 January 2026 | Accepted: 14 January 2026  \nKeywords: epigenetic modifications | hepatocellular carcinoma | signalling pathways | solid tumour immunotherapy | T cell exhaustion | tumour metabolomics  \nABSTRACT  \nHepatocellular carcinoma (HCC), accounting for over 90% of primary liver cancers, remains a major global challenge for healthcare professionals. While immunotherapy has transformed the landscape of cancer treatment, its success is often limited by immune resistance, particularly through T cell exhaustion which remains a major barrier to effective immune responses in solid tumours, including HCC. As tumours progress, T cells undergo a gradual loss of functionality due to continuous antigen exposure and fail to exert effective anti-tumour responses. During this process, alterations in the epigenome, transcriptome, signalling pathways, and tumour metabolome, in addition to interactions with other cells in the tumour microenvironment, efficiently contribute to T cell exhaustion. Restoring T cell function brings hope for improving therapy outcomes and providing new treatment modalities for HCC patients. In this review, we explore the key cellular and molecular mechanisms driving T cell exhaustion, including the roles of immunosuppressive cells, metabolic stress, and epigenetic alterations focusing on HCC. We also discuss current and emerging strategies aimed at preventing or reversing T cell exhaustion, such as epigenetic modulation, immune checkpoint blockade, metabolic reprogramming, and combination therapies. Understanding these interconnected pathways is critical for designing more effective immunotherapy-based approaches for liver cancer.  \n1 | Introduction  \nHepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and the third most fatal cancer, accounting for 757,948 deaths in 2022 [1] . While our understanding of cancer aetiology, including genomic and microenvironment factors, is improving, the majority of patients are still diagnosed at an advanced stage, with less than 30% eligible for curative treatment options [2] . This highlights the urgent need for effective  \nsystemic therapies for the majority of HCC patients with advanced diseases. Immunotherapy provides an effective and safe approach for treating solid tumours, leading to prolonged survival and manageable side effects [3] .  \nImmune checkpoint blockade and chimeric antigen receptor","cbCaicy6rUhk1s6T","https://ap.wps.com/l/cbCaicy6rUhk1s6T","pdf",1614294,26,"English","# Introduction\n## T cell exhaustion as an immunotherapy barrier in HCC\n## Tumour microenvironment and progression-related dysfunction\n## Mechanistic basis: epigenome, transcriptome, signalling and metabolome\n## Therapeutic strategies: checkpoint blockade, epigenetic and metabolic approaches","[{\"question\":\"Why is T cell exhaustion considered a major barrier to immunotherapy in hepatocellular carcinoma (HCC)?\",\"answer\":\"In HCC, continuous antigen stimulation and an immunosuppressive tumour microenvironment drive T cells into a dysfunctional state known as T cell exhaustion, which prevents effective anti-tumour responses.\"},{\"question\":\"How do tumour-related molecular changes contribute to T cell exhaustion?\",\"answer\":\"As tumours progress, alterations in the epigenome, transcriptome, signalling pathways, and tumour metabolome—along with interactions within the tumour microenvironment—efficiently support the development of T cell exhaustion.\"},{\"question\":\"What types of strategies are discussed for preventing or reversing T cell exhaustion?\",\"answer\":\"The review discusses approaches including epigenetic modulation, immune checkpoint blockade, metabolic reprogramming, and combination therapies designed to restore T cell function and improve therapy outcomes.\"}]","T Cell Exhaustion in Hepatocellular Carcinoma - A Substantial Barrier in Immunotherapy | PDF",1790099057,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33f6cb33b6d8a12f975debd0d8627a8b.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12c8cc2a5d0622c06d502ddfe2f4d632.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18a89393945f3744801201c2490eebe0.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc8ae66bd81354ed5673c61f80e3308c.webp",980,1287]